Keywords: cogentus, initiates, ph, iii, cgt-2168, trial, usa

Cogentus initiates Ph III CGT-2168 trial

Article | 28 January 2008

Print This

The USA's Cogentus Pharmaceuticals has enrolled the first patient in a pivotal Phase III study of its novel combination medicine ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in